Impact BioMedical, Inc. (IBO)
NYSE: IBO · Pharmaceutical Preparations · Houston, TX · filing with the SEC since 2021
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
| Report filed | Mar 11, 2026 | Mar 28, 2025 | Feb 20, 2024 | · |
| Revenue | 32 | · | · | 50 |
| Cost of revenue | 424 | · | · | · |
| Research and development | 340 | 278 | 1,685r | 1,226 |
| Selling, general and administrative | 873 | 718 | 315 | 325 |
| Sales and marketing | 24 | 633 | 65 | · |
| Total operating expenses | · | 28,753 | 4,028 | · |
| Total costs and expenses | 4,314 | 28,753 | 4,028 | 3,454 |
| Operating income | -4,282 | -28,753 | -4,028 | -3,404 |
| Interest expense | 793 | 1,065 | 444 | 462 |
| Interest and investment income | · | · | 13 | 24 |
| Interest income (expense), net | 13 | 13 | 13 | · |
| Income before income taxes | -14,450 | -24,737 | -4,407 | -7,876 |
| Income tax expense | -2,580 | 33 | · | -621 |
| Net income including non-controlling interests | -11,870 | -24,770 | -4,407 | · |
| Net income to non-controlling interests | -32 | -62 | -71 | · |
| Net income | -11,838 | -24,708 | -4,336r | -7,255 |
| Net income to common shareholders | · | · | -4,336 | -7,051 |
| Earnings per share, basic | -0.38 | -2.30 | -0.07 | -0.10 |
| Earnings per share, diluted | -0.38 | -2.30 | -0.07 | -0.10 |
| Weighted average shares, basic | 31,550,457 | 10,757,147 | 60,248,078 | 70,496,041 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfGoodsAndServicesSoldResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseSales and marketing the cost of finding and serving customers
us-gaap:SellingAndMarketingExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesTotal costs and expenses every operating cost, the cost of revenue included
us-gaap:OperatingCostsAndExpenses
us-gaap:CostsAndExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income to non-controlling interests the share that belongs to minority holders
us-gaap:NetIncomeLossAttributableToNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic